Investor Atlas

2080 Ventures · Investor research

63 Series C investors targeting Switzerland

Compare 63 Series C investors targeting Switzerland. Review the selection, investor types and reported focus with 2080 Ventures.

63matching investors
0individual investors
63organizations

What this selection covers

This guide contains 63 distinct directory identities matching target markets: Switzerland; funding stages & types: Series C. Counts describe Investor Atlas coverage, not the size of the market or currently available capital.

“Targeting Switzerland” means the source explicitly lists this investment market. These investors may be headquartered elsewhere. Worldwide or regional labels are not expanded into individual countries.

Series C is a reported funding-stage or financing-type tag. Business milestones such as prototype or early revenue are kept separate.

Investor types represented: Venture Capital (55), Private Equity (7), Corporate Venture Capital (5), Family Office (4).

Common reported sector tags: Healthcare (48), SaaS (41), Fintech (37), Consumer (32). Investors can have multiple tags.

Prepare a focused approach

Start with the sector and business model you operate in, then narrow by funding round, target market and investor type.

Before pitching for Switzerland, confirm incorporation requirements, team location and whether the mandate supports market entry or only established local operations.

For Series C, show the evidence already achieved, the next milestone and a budget connecting the raise to that milestone. Confirm expected round size and ownership.

  1. Check the current mandate and recent investments.
  2. Confirm check size, lead or follow preference, and company eligibility.
  3. Identify the relevant partner and published pitch route.
  4. Explain your customer evidence, raise and specific reason for approaching this investor.

Explore the 63 matching investors

Listed alphabetically, without ranking by performance or likelihood of investment. Full profiles, investment criteria and available contact details require sign-in.

InvestorInvestor typeResearch
360 Capital
Venture CapitalView profile ↗
5AM Ventures
Venture CapitalView profile ↗
Abingworth
Venture CapitalView profile ↗
Adjuvant Capital
Venture CapitalView profile ↗
Altos Ventures
Venture CapitalView profile ↗
Andreessen Horowitz
Venture CapitalView profile ↗
Atlantic Bridge
Venture CapitalView profile ↗
Atomico
Venture CapitalView profile ↗
Balderton Capital
Venture CapitalView profile ↗
Bessemer Venture Partners
Venture CapitalView profile ↗
Boehringer Ingelheim Venture Fund
Venture Capital, Corporate Venture CapitalView profile ↗
Bosch Ventures
Venture Capital, Corporate Venture CapitalView profile ↗
BREEGA
Venture CapitalView profile ↗
btov Partners
Venture CapitalView profile ↗
Cipio Partners
Venture CapitalView profile ↗
Creandum
Venture CapitalView profile ↗
CVC Capital Partners
Private EquityView profile ↗
Demeter
Venture CapitalView profile ↗
EQT Ventures
Venture Capital, Family OfficeView profile ↗
Eurazeo
Private EquityView profile ↗
Extorel
Family OfficeView profile ↗
Fin Capital
Venture CapitalView profile ↗
Finch Capital
Venture CapitalView profile ↗
Forbion Capital Partners
Venture CapitalView profile ↗
Foresite Capital
Venture CapitalView profile ↗
General Catalyst
Venture CapitalView profile ↗
Gilde Healthcare
Venture CapitalView profile ↗
Gimv
Private EquityView profile ↗
Global Founders Capital
Venture Capital, Family OfficeView profile ↗
HBM Partners
Private EquityView profile ↗
HealthCap
Venture CapitalView profile ↗
Highland Europe
Venture CapitalView profile ↗
IDInvest Partners
Private EquityView profile ↗
Index Ventures
Venture CapitalView profile ↗
Inveready
Venture CapitalView profile ↗
Kurma Partners
Venture CapitalView profile ↗
Mangrove Capital Partners
Venture CapitalView profile ↗
Medicxi
Venture CapitalView profile ↗
MVM Life Science Partners
Venture CapitalView profile ↗
Nauta Capital
Venture CapitalView profile ↗
Naxicap Partners
Private EquityView profile ↗
Novartis Venture Fund
Venture Capital, Corporate Venture CapitalView profile ↗
Novo Holdings
Venture Capital, Corporate Venture CapitalView profile ↗
Orange Ventures
Venture Capital, Corporate Venture CapitalView profile ↗
Paradigm
Venture CapitalView profile ↗
Permira
Private EquityView profile ↗
Piton Capital
Venture CapitalView profile ↗
Prime Ventures
Venture CapitalView profile ↗
Reimann Investors
Venture Capital, Family OfficeView profile ↗
Revolution Ventures
Venture Capital, AcceleratorView profile ↗
Route 66 Ventures
Venture CapitalView profile ↗
Runa Capital
Venture CapitalView profile ↗
Sequoia Capital
Venture CapitalView profile ↗
Sofinnova Partners
Venture CapitalView profile ↗
Summit Partners
Venture CapitalView profile ↗
SV Health Investors
Venture CapitalView profile ↗
Target Global
Venture CapitalView profile ↗
Target Partners
Venture CapitalView profile ↗
TVM Capital
Venture CapitalView profile ↗
Union Square Ventures
Venture CapitalView profile ↗
Ventech
Venture CapitalView profile ↗
Versant Ventures
Venture CapitalView profile ↗
Wellington Partners
Venture CapitalView profile ↗

How these guides are compiled. Source-reported criteria may change. A listing does not confirm current investment activity.